{
    "code": "60001048",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001048",
    "time": "2021-05-14 05:05:35",
    "許可證字號": "衛部菌疫輸字第001048號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/11\/24",
    "發證日期": "106\/11\/24",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000104802",
    "中文品名": "&quot;貝靈&quot; 優利勁人體免疫球蛋白皮下注射液20%",
    "英文品名": "Hizentra",
    "適應症": "成人、兒童和青少年（0-18歲）之替代療法：\r\n(1) 原發性免疫不全症(primary immunodeficiency syndrome)（例如：先天性丙種免疫球蛋白缺乏症(congenital agammaglobulinemia)和丙種免疫球蛋白過低症(hypogammaglobulinemia)、常見變異性免疫不全症(common variable immunodeficiency)、嚴重複合型免疫不全症(severe combined immunodeficiency)及 Wiskott-Aldrich氏症候群）。\r\n(2) 慢性淋巴性白血病(chronic lymphocytic leukemia)引致低丙種免疫球蛋白血症及復發性細菌感染，且預防性抗生素治療無效或不適合接受(contra-indicated)預防性抗生素治療的病人。\r\n(3)多發性骨髓瘤(multiple myeloma)引致低丙種免疫球蛋白血症及復發性細菌感染的病人者。\r\n(4) 異體造血幹細胞移植前後引致丙種免疫球蛋白過低。\r\n\r\n成人，兒童和青少年的免疫調節療法（0-18歲）\r\nHizentra可作為慢性脫髓鞘多發性神經炎（CIDP）病人的維持療法，於IVIg治療穩定後使用。",
    "劑型": "27D注射液劑",
    "包裝": "100支以下盒裝 5、10、20、50毫升玻璃小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "血液衍生產品",
    "監視期限": "",
    "主成分略述": "IMMUNOGLOBULIN HUMAN",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "620117O278  傑特貝林有限公司",
    "申請商地址": "臺北市信義區基隆路1段333號16樓(1612室)",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0111100  CSL BEHRING AG",
            "製造廠廠址": "WANKDORFSTRASSE 10, 3014 BERN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "原料藥製造廠及包裝廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6131041824  吉發企業股份有限公司中和廠",
            "製造廠廠址": "新北市中和區橋和路116號6樓、6樓之1、6樓之2及6樓之3",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FCH0111000  CSL BEHRING AG",
            "製造廠廠址": "WANKDORFSTRASSE 10 CH-3000 BERN 22, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "公司"
        },
        {
            "製造廠名稱": "FCH8062000  CSL BEHRING AG",
            "製造廠廠址": "UNTERMATTWEG 8, CH-3027 BERN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "二級包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8004000603",
            "成分名稱": "IMMUNOGLOBULIN HUMAN",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG\/ML"
        }
    ],
    "仿單外盒": [
        {
            "title": "貝靈 優利勁人體免疫球蛋白皮下注射液20%(598x332mm)_20200904-109-09-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001048&Seq=003&Type=9"
        },
        {
            "title": "標籤、外盒(1g, 2g, 4g)-108-10-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001048&Seq=011&Type=8"
        }
    ]
}